Next Article in Journal
COVID-19 Vaccine Uptake among US Adults According to Standard Occupational Groups
Next Article in Special Issue
Electronic Package Leaflets for Vaccines: What Are People’s Perceptions in Italy?
Previous Article in Journal
Nurses’ Influenza Vaccination and Hesitancy: A Systematic Review of Qualitative Literature
Previous Article in Special Issue
Internal and External Motivations and Risk Perception toward COVID-19 Vaccination in Adolescents in the U.S.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy

Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, Italy
*
Author to whom correspondence should be addressed.
Submission received: 27 April 2022 / Revised: 10 June 2022 / Accepted: 20 June 2022 / Published: 22 June 2022
(This article belongs to the Special Issue Feature Papers of Vaccines and Society)

Abstract

:
Evidence on the human papillomavirus (HPV) vaccine shows that it is effective in reducing the burden of HPV-related diseases. For more than 15 years the HPV vaccine has been offered free of charge in Italy to girls from the age of 12. Over time, the free offer of the HPV vaccine has also been extended to boys and to young adults at risk of developing HPV lesions. Despite the HPV vaccine’s effectiveness and availability, vaccination coverage is low in Italy, with a reported value of 46.5% in 2020. Furthermore, in the southern administrative regions, vaccination coverage is even lower than national values, with 25.9% coverage in Sicily. A cross-sectional study was conducted among university and high school students in the Palermo area (Sicily, Italy) in order to identify the determinants of HPV vaccination adherence by using a questionnaire that investigated factors of HPV vaccine practice. The study explored the behavioral attitude by using the Health Belief Model (HBM), and also used the SILS test and the METER test to investigate the level of health literacy (HL). Overall, 3,073 students were enrolled, and less than a third reported they had completed the vaccination schedule (n = 925, 30.1%). Multivariable analysis showed that the factors directly associated with the adherence to HPV vaccination were female sex (OR = 4.43, p < 0.001), high HBM total score (OR = 4.23, p < 0.001), good HL level (OR = 1.26, p = 0.047), parents (OR = 1.78, p = 0.004), general practitioner (OR = 1.88, p = 0.001), and educational material provided by public vaccination services (OR = 1.97, p = 0.001) as HPV vaccine information sources. Further health-promotion programs focused on improving HL and perception of the HPV vaccine’s benefits should be implemented in order to achieve the desirable 95% vaccination coverage.

1. Introduction

Human papillomavirus (HPV) infection is the commonest sexually transmitted viral infection worldwide; this small virus is highly common and widespread, with a marked tropism for skin and mucous membranes [1]. There are more than 200 types of HPV that can be classified in different groups according to the level of oncogenic risk [2]. HPV is a well-established cause of cervix, anogenital region (anus, vulva, vagina, and penis), and head and neck cancers, as well as genital warts, in both sexes [3]. Worldwide, cervical cancer is by far the most common HPV-related neoplasm, and it represents the fourth type of cancer both by incidence and mortality, with more than 560,000 new cases and more than 310,000 deaths per year [4]. Nearly all cases of cervical cancer can be attributed to HPV infection. There is no specific treatment to counteract HPV infection, and prevention is the most effective strategy, including both immunization and cervical cancer screening. The elimination of cervical cancer is today a global public health goal launched by the WHO in 2018, with the aim to vaccinate at least 90% of the target female population and significantly increase vaccination for boys by 2030 [5]. Currently, 30 European countries have introduced HPV vaccination into their national immunization programs recommending vaccination for preadolescent females, and 17 countries for males [6]. In Italy, vaccination has been offered actively and free of charge to girls in the twelfth year of life since 2007. Afterward, the active offer was gradually extended to older girls, and since 2015 some administrative regions, including Sicily, have begun to offer the vaccine to boys as well [7]. Despite the proven efficacy and safety profile, vaccination coverage for HPV is still unsatisfactory in several European countries; for example, in Italy, the achieved coverage of HPV vaccination was 47% in 2015, far from the desirable 95% coverage [8,9]. The HPV vaccination coverage suffered a further decline in 2020 due to difficulties and obstacles related to the COVID-19 pandemic; considering the whole Italian territory, vaccination coverage for HPV was 30.3% for girls born in 2008. Even in Sicily the vaccination rate dropped drastically, with values of 34.6%, 35.9%, and 22.6% for females and 26.9%, 24%, and 14.9% for males in the 2006, 2007, and 2008 birth cohorts, respectively [10].
The most frequent reasons reported in the literature for vaccination refusal were fear and concerns about adverse effects, safety and newness, poor perception of risk related to infection and subsequent diseases, lack of perception of direct clinical value (especially for males), and lack of accurate information [11,12]. There are several cognitive elements that can impact vaccination adherence. The cognitive models can explore people’s perceptions about benefits of prevention and propensity to adhere to the preventive practices, one example is the Health Belief Model (HBM) [13]. Developed in the 1950s, the HBM continues to be one of the most accredited and widely used theories to investigate people’s perceptions about the benefits of prevention and, at the same time, obstacles associated with adhering to preventive practices, thus allowing the model to predict the behavior adopted, such as the decision to get vaccinated [13,14]. Another element that can influence vaccination adherence is vaccination literacy. It originates from health literacy (HL), and identifies the degree to which people have the capacity to obtain, process, and understand basic information and services to make appropriate health decisions [15,16]. Poor HL is associated with a lower use of preventive services and with a reduced adoption of protective behaviors such as immunization [17]. There are numerous tools used to measure HL, such as short questionnaires and tests suitable for evaluating multiple skills: the Test of Functional Health Literacy in Adults (TOFHLA), which measures reading fluency; the Rapid Estimate of Adult Literacy in Medicine (REALM) test, which evaluates pronunciation and vocabulary domain; the rapid test of Newest Vital Sign (NVS) screening on the understanding of nutritional information; the Health Activities Literacy Scale (HALS) with prose elements; the Single Item Literacy Screener (SILS) test, which consists of a single question; and the Medical Term Recognition Test (METER), which consists of a list of 70 medical and nonmedical terms [18,19,20].
The main aim of this study was to identify the determinant factors for HPV vaccination acceptance by exploring the cognitive models and HL level of adolescent and young adults in a low vaccination coverage setting.

2. Materials and Methods

A cross-sectional study was conducted among students and young adults, including males and females (13–26 years old). The survey was conducted through the administration of a questionnaire to young adults attending the University of Palermo and young students attending high schools in the Palermo area from April to December 2019. The questionnaire consisted of 4 different sections. The first one concerned sociodemographic information, with questions about age, sex, family, mother’s and father’s educational levels, and economic status. The second one included questions on exposure to risk factors and personal behaviors such as smoking, drinking alcohol, physical activities, dietary habits, and sexual behaviors. The third section focused on knowledge about HPV infection and vaccination. In this section, the questions also explored compliance with the vaccination schedule based on the number of doses received, which allowed the identification of vaccinated and unvaccinated students. The fourth section consisted of the HBM section, which investigated, through 15 items, the six different domains of the model and, in this case, the benefits related to general vaccinations and HPV vaccination, barriers to general vaccination and the HPV vaccine, susceptibility to HPV infection, and severity of diseases related to HPV infection. The available response options, according to a Likert scale, ranged from 1 = absolutely not to 5 = very highly. The HMB domain score was then recategorized according to the following value: 0 = 1(”I strongly disagree”) and/or 2 (”I disagree”) or 1 = 3 (”Neither I agree nor I disagree”), 4 (”I agree”), and/or 5 (”I strongly agree”). The recategorized score was used for all questions, and the cut-off was selected by using the median value for “High HBM” (score ≥ 12), which reflected a greater awareness of the importance of vaccination; and “Medium-Low” HBM (score < 12), which reflected a lower tendency to adhere to vaccination. In this section, we also included two self-administering tests for the evaluation of HL. The first was the SILS test, consisting of a single question (i.e., How often do you need to have someone helping you when you read instructions, pamphlets or other written material from your doctor or pharmacy?) with five answer options (1 = never; 2 = rarely; 3 = sometimes; 4 = often; 5 = always) [20]. The second was the METER test, which consists of a list with 70 terms, including 40 medical and 30 nonmedical terms printed on a single page; the score is assigned based on the number of identified medical words. According to the score, it was possible to identify three levels of HL as follows: 0–20 = low level; 21–34 = marginal level; 35–40 = adequate level [19].

3. Statistical Analysis

The normality of the distribution for the quantitative variables was assessed with the skewness and kurtosis test. The absolute and relative frequencies were calculated for the qualitative variables. The association of quantitative variables normally and not normally distributed with adhesion to the HPV vaccination were evaluated respectively with the Student’s t-test and with the Wilcoxon and Mann–Whitney test, while for the qualitative variables, the chi-squared test was used. A univariable logistic regression analysis was performed to evaluate the factors associated with acceptance of HPV vaccination. Study covariates that were found to be significantly associated with adherence to the vaccination after the univariable analysis (p < 0.05) were evaluated in a multivariable logistic regression model. All collected data were analyzed using Stata MP v14.2 statistical software.

4. Results

Overall, 3073 students were enrolled, of which 2081 (67.7%) were university students (14.7% attending medical courses) and 992 (32.3%) were high school students. The majority of people interviewed were female (71.1%) aged 21–23 years (26.1%). The parents of the interviewed students were more frequently workers (father 99% and mother 85.6%), and the economic status was more frequently defined as good (47.9%) or acceptable (44.4%). As for lifestyle habits, 22% of the people enrolled reported to be smokers, and 71.5% to drink alcohol occasionally. With regard to sexual habits, 48.5% of participants were in an exclusive relationship at the time of the survey, 91.1% were heterosexual, and 43% had their sexual debut between the ages of 15 and 18. More than half said they used condoms regularly during sexual intercourse, while 22.3% did not use any contraceptive method. The analysis also made a comparison between vaccinated and unvaccinated students. In details, vaccinated students were more frequently female (88.3% vs. 63.7%, p < 0.001), attending high school (38.4% vs. 29.7%, p < 0.001), and 13–14 years old (10.4% vs. 4.7%, p < 0.001). It was also found that those who adhered more frequently to vaccination were students with working mothers (88.9% vs. 84.2%, p < 0.001) with a good economic condition (53.5% vs. 45.4%, p < 0.001) and bisexual students (6.2% vs. 3.9%, p < 0.028) (Table 1).
Most of the respondents reported to be informed about sexually transmitted infections (STIs) (87.8%), but only one-third (34.9%) recognized HIV as the most frequent sexually transmitted agent, followed by genital herpes (28.2%). The majority of students had a high level of knowledge of HPV infection and vaccination: the highest level of knowledge was on HPV transmission (91.8%), followed by association between HPV and cervical cancer (65.3%), but many of them believed that efficacious therapies are available (80.1%). The main source of information on HPV vaccination was school (21%), followed by parents (17.3%) and pediatricians or general practitioners (16.8%). Less than a third of the students said they had been immunized against HPV and completed the vaccination cycle (n = 925, 30.1%), as reported in Table 2. Furthermore, among those unvaccinated, there were students more frequently informed about the vaccine at school (16.7% vs. 22.9%, p < 0.001), through the internet (6.7% vs. 14.5%, p < 0.001), by media (4.4% vs. 10.2%, p < 0.001), or by friends (0.8% vs. 5.1%, p < 0.001) (Table 2).
With regard to HL, the SILS test results showed that the majority of respondents believed they did not need any help when reading or understanding medical indications (43.6% “Rarely” and 31.6% “Never”). When evaluating the HL level with the METER test, 52.1% (n = 1610) of them had a good score, identifying 35–40 correct terms. The results obtained regarding the HBM investigation showed that 35.7% of the students had a high level of HBM, with a score greater than or equal to 12. Furthermore, vaccinated in comparison to unvaccinated students more frequently answered “Rarely” to the SILS test (47.1% vs. 42%, p = 0.005) and had a higher HBM score (56.8% vs. 26.7%, p < 0.001) (Table 3).
Considering the sample of students interviewed, the factors directly associated with HPV vaccination adherence in the multivariable analysis were female sex (OR = 4.43, p < 0.001), high HBM total score (OR = 4.23, p < 0.001), good HL level, and “Rarely” response in the SILS test (OR = 1.26, p = 0.047). Furthermore, having parents (OR = 1.78, p = 0.004), general practitioners (OR = 1.88, p = 0.001), and educational material provided by public vaccination services (OR = 1.97, p = 0.001) as HPV vaccine information sources were also directly associated with being vaccinated. On the other hand, factors inversely associated with vaccination adherence were: being 17–18 years old (OR = 0.19, p < 0.001); and HPV vaccine information sources such as school (OR = 0.67, p = 0.05), internet (OR = 0.62, p = 0.043), and friends (OR = 0.28, p = 0.007) (Table 4).

5. Discussion

The study revealed low vaccination HPV coverage among adolescents and young adults in the Palermo area. Although the HPV vaccine is effective in reducing the burden of HPV-related diseases, the vaccine’s acceptability should be increased to achieve the desirable 95% vaccination coverage [21].
In this study, a factor associated with vaccination adherence was the female sex. The difference in vaccine acceptability was already highlighted in similar studies. A few studies showed that females had a higher knowledge of HPV infection and prevention strategies, such as screening, that could increase the probability of being vaccinated [22,23]. An approach to increasing adherence in males might be to focus on the role of the vaccine in protecting against HPV infections. This message should oppose the general idea that the HPV vaccine aims at exclusively preventing cervical cancer, which affects only females [24].
This survey found that the probability of being vaccinated could vary according to the different age groups. In particular, the age cohort between 17 and 18 years old was less vaccinated. An explanation of this finding could be that this age might correspond to sexual debut, exposing young people to a high risk of HPV infection [25]. Furthermore, adolescents at this age do not talk about health issues with their family for several reasons: limited understanding of the infection, uncertainty about the need for vaccination, and embarrassment in discussing sexual habits with parents [26]. Consequently, health-promotion campaigns are needed to encourage parents to talk with their children about their sexual habits and the related medical topics.
Another factor directly associated with HPV vaccination was a high HBM score. The influence of behavioral characteristics was already explored in other studies. For example, in Sweden, girls with a higher HBM score in HPV disease susceptibility had a higher intention to adopt preventive strategies [27]. On the other hand, a previous study conducted in Sicily showed a higher influence of HPV vaccinations’ perceived benefits in preventive strategy acceptance [28]. According to these findings, an in-depth analysis of the behavioral model using a theoretical framework such as HBM should be performed before selecting the intervention to increase HPV vaccine adherence.
Moreover, informative sources on HPV vaccination can play a major role in the decision-making process. For example, among the sources directly associated with HPV vaccination, there were general practitioners, public health services and parents. The associations between these sources of information and vaccination acceptability was confirmed by other studies [29,30]. Furthermore, an exponential effect could be reached when several informative sources from the medical perspective used a common shared message for young adults.
On the other hand, there were sources inversely associated with HPV vaccination adherence: the internet, school and friends. The role of the internet in providing information on the HPV vaccine is particularly ambiguous because there are many websites that deal with the topic, but some of these are managed by people who are not competent in the medical field [31]. For this reason, it must be considered very useful to teach young people to seek information on medical topics only on authorized and reliable websites. For example, in 2000, the European Union founded the MedCERTAIN certification system, which has rating-based content to inform users on the quality of websites [32]. Another tool used to increase reliability of online sources is the HONcode, a certified logo that testifies to the truthfulness of the sources and to the author’s credentials [33].
Another source of information inversely associated with HPV vaccination adherence was the school. A lack of medical information can be the cause of a changing role of schools as informative sources. Indeed, in 2004, the Italian law relating to school medical service was repealed, as it was dated and referred to a very different epidemiological context. Since then, the school health service has been marginally managed through the responsibility of local pediatricians [34]. This theory is in accordance with other studies showing that the active presence of health professionals in a school setting can greatly improve students’ acceptability of the HPV vaccine. For example, in Sweden, face-to-face interviews between nurses and students led to improvements in beliefs about HPV prevention; while in Norway, there was a great increase in vaccination coverage after the start of the school-based HPV vaccination program [35,36].
Moreover, friends were revealed as a source of information that was inversely associated with HPV vaccination. In the literature, friends had a mixed role as informative sources. For example, a study conducted in the U.S.A. identified friends among the most common sources of information, highlighting how the decision-making process for HPV vaccination was influenced by the contexts of daily life [37]. On the other hand, another U.S.A. survey aimed at guiding future interventions to target peer influence on medical decisions, and it found that friends negatively affected young adults’ knowledge about HPV [38]. The different levels of education, as well as the social and cultural context, could be responsible for these conflicting results [39]. It should be noted that the people interviewed had a low level of knowledge about HPV diseases or the HPV vaccine, and they could also have friends with a low level of knowledge. Consequently, it would be advisable for young people to be informed about HPV vaccination by more accredited and competent sources, rather than by word of mouth among friends.
A final consideration should be made on HL. Indeed, the analysis showed that students with a good level of HL had a higher probability of being vaccinated against HPV. The higher vaccine acceptance could be related to the linking of HL with higher knowledge of both the virus and available vaccines [40]. This study was the first to our knowledge to demonstrate an association between a high level of HL and an effective adherence to HPV vaccination. This evidence can allow the building of preventive strategies based on the Sicilian HL level. Indeed, there are several countries that have implemented HL improvement policies, and that understood how it can represent an important tool for public health. For example, in Australia, the “National Declaration on Health Literacy” was published in 2014, outlining three areas of intervention: (i) embedding health literacy into systems; (ii) ensuring effective communication; and (iii) integrating health literacy into education [41].
The main limitation of this study was the recall bias due to the delay between HPV vaccination practice and questionnaire administration. Furthermore, data on HPV vaccination schedule were self-reported by those interviewed to ensure anonymization of the questionnaires, and therefore may have been subject to biases and limitations. Notwithstanding previous limitations, this study explored the association among HPV vaccination acceptance, literacy level, and behavioral motivation after 15 years of vaccine implementation in a population with low vaccination coverage.

6. Conclusions

HPV vaccination acceptance is directly influenced by the level of HL, the perception of severity, susceptibility to disease, vaccination barriers, and benefits. This evidence should be used to build interventions that improve HPV vaccine acceptability. However, the role of a shared message by the strongly associated informative sources and the implementation of health information campaigns in weak informative settings, such as in schools, also can allow for achieving desirable vaccination coverage rates.

Author Contributions

Conceptualization, A.F., F.V. and V.R.; methodology, A.F. and V.R.; software, V.R.; validation, A.F.; formal analysis, A.F. and V.R.; investigation, A.F.; resources, A.C. and F.V.; data curation, A.F. and V.R.; writing—original draft preparation, A.F.; writing—review and editing, L.R., P.I., A.C., F.V. and V.R.; visualization, L.R., P.I. and V.R.; supervision, A.C. and V.R.; project administration, V.R.; funding acquisition, A.F., A.C., F.V. and V.R. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was approved by the Palermo 1 Ethics Committee (Protocol No. 6/2017 of 5 June 2017).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

Data will be made available by the corresponding author upon reasonable request.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. WHO. Human Papillomavirus (HPV) and Cervical Cancer. Available online: https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer (accessed on 22 February 2022).
  2. IARC. Monographs on the Identification of Carcinogenic Hazards to Humans (Last Update: 30 November 2021). Available online: https://monographs.iarc.who.int/agents-classified-by-the-iarc/2021/ (accessed on 22 February 2022).
  3. Human Papillomavirus and Related Diseases Report 2021. Available online: https://hpvcentre.net/statistics/reports/XWX.pdf (accessed on 22 February 2022).
  4. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Europe’s Beating Cancer Plan—Communication from the Commission to the European Parliament and the Council. Available online: https://ec.europa.eu/health/system/files/2022-02/eu_cancer-plan_en_0.pdf (accessed on 22 February 2022).
  6. ECDC. Human Papillomavirus Infection: Recommended Vaccinations. Available online: https://vaccine-schedule.ecdc.europa.eu/Scheduler/ByDisease?SelectedDiseaseId=38&SelectedCountryIdByDisease=-1 (accessed on 22 February 2022).
  7. Epicentro. HPV Infection and Cervical Cancer. 2015. Available online: https://www.epicentro.iss.it/hpv/ (accessed on 22 February 2022).
  8. Piano Nazionale di Prevenzione Vaccinale 2017–2019. Available online: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf (accessed on 22 February 2022).
  9. ECDC. Guidance on HPV Vaccination in EU Countries: Focus on Boys, People Living with HIV and 9-Valent HPV Vaccine Introduction. 2020. Available online: https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-on-HPV-vaccination-in-EU-countries2020-03-30.pdf (accessed on 22 February 2022).
  10. Italian Ministry of Health. Vaccination against Papilloma Virus (HPV)—Vaccine Covers. Available online: https://www.salute.gov.it/portale/documentazione/p6_2_8_3_1.jsp?lingua=italiano&id=27 (accessed on 22 February 2022).
  11. Holman, D.M.; Benard, V.; Roland, K.B.; Watson, M.; Liddon, N.; Stokley, S. Barriers to human papillomavirus vaccination among US adolescents: A systematic review of the literature. JAMA Pediatr. 2014, 168, 76–82. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Nicol, A.F.; Andrade, C.V.; Russomano, F.B.; Rodrigues, L.L.; Oliveira, N.S.; Provance, D.W., Jr. HPV vaccines: A controversial issue? Braz. J. Med. Biol. Res. 2016, 49, e5060. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Janz, N.K.; Becker, M.H. The Health Belief Model: A decade later. Health Educ. Q. 1984, 11, 1–47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Rosenstock, I.M.; Strecher, V.J.; Becker, M.H. Social learning theory and the Health Belief Model. Health Educ. Q. 1988, 15, 175–183. [Google Scholar] [CrossRef]
  15. Ratzan, S.C. Vaccine literacy: A new shot for advancing health. J. Health Commun. 2011, 16, 227–229. [Google Scholar] [CrossRef]
  16. Lorini, C.; Santomauro, F.; Donzellini, M.; Capecchi, L.; Bechini, A.; Boccalini, S.; Bonanni, P.; Bonaccorsi, G. Health literacy and vaccination: A systematic review. Hum. Vaccin Immunother. 2018, 14, 478–488. [Google Scholar] [CrossRef] [Green Version]
  17. Berkman, N.D.; Sheridan, S.L.; Donahue, K.E.; Halpern, D.J.; Crotty, K. Low health literacy and health outcomes: An updated systematic review. Ann. Intern. Med. 2011, 155, 97–107. [Google Scholar] [CrossRef]
  18. Baker, D.W. The meaning and the measure of health literacy. J. Gen Intern. Med. 2006, 21, 878–883. [Google Scholar] [CrossRef] [Green Version]
  19. Rawson, K.A.; Gunstad, J.; Hughes, J.; Spitznagel, M.B.; Potter, V.; Waechter, D.; Rosneck, J. The METER: A brief, self-administered measure of health literacy. J. Gen Intern. Med. 2010, 25, 67–71. [Google Scholar] [CrossRef] [Green Version]
  20. Morris, N.S.; MacLean, C.D.; Chew, L.D.; Littenberg, B. The Single Item Literacy Screener: Evaluation of a brief instrument to identify limited reading ability. BMC Fam. Pract. 2006, 7, 21. [Google Scholar] [CrossRef] [PubMed]
  21. Restivo, V.; Costantino, C.; Amato, L.; Candiloro, S.; Casuccio, A.; Maranto, M.; Marrella, A.; Palmeri, S.; Pizzo, S.; Vitale, F.; et al. Evaluation of the Burden of HPV-Related Hospitalizations as a Useful Tool to Increase Awareness: 2007–2017 Data from the Sicilian Hospital Discharge Records. Vaccines 2020, 8, 47. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Preston, S.M.; Darrow, W.W. Are Men Being Left Behind (Or Catching Up)? Differences in HPV Awareness, Knowledge, and Attitudes between Diverse College Men and Women. Am. J. Mens. Health 2019, 13, 1557988319883776. [Google Scholar] [CrossRef] [PubMed]
  23. Restivo, V.; Costantino, C.; Marras, A.; Napoli, G.; Scelfo, S.; Scuderi, T.; Casuccio, A.; Cernigliaro, A.; Giusti, A.; Spila Alegiani, S. Pap Testing in a High-Income Country with Suboptimal Compliance Levels: A Survey on Acceptance Factors among Sicilian Women. Int. J. Environ. Res. Public Health 2018, 15, 1804. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Osazuwa-Peters, N.; Adjei Boakye, E.; Mohammed, K.A.; Tobo, B.B.; Geneus, C.J.; Schootman, M. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev. Med. 2017, 99, 299–304. [Google Scholar] [CrossRef]
  25. Crochard, A.; Luyts, D.; di Nicola, S.; Gonçalves, M.A. Self-reported sexual debut and behavior in young adults aged 18–24 years in seven European countries: Implications for HPV vaccination programs. Gynecol. Oncol. 2009, 115, S7–S14. [Google Scholar] [CrossRef]
  26. Williams, K.; Forster, A.; Marlow, L.; Waller, J. Attitudes towards human papillomavirus vaccination: A qualitative study of vaccinated and unvaccinated girls aged 17–18 years. J. Fam. Plann. Reprod. Health Care. 2011, 37, 22–25. [Google Scholar] [CrossRef]
  27. Grandahl, M.; Larsson, M.; Dalianis, T.; Stenhammar, C.; Tydén, T.; Westerling, R.; Nevéus, T. Catch-up HPV vaccination status of adolescents in relation to socioeconomic factors, individual beliefs and sexual behaviour. PLoS ONE 2017, 12, e0187193. [Google Scholar] [CrossRef] [Green Version]
  28. Restivo, V.; Costantino, C.; Fazio, T.F.; Casuccio, N.; D’Angelo, C.; Vitale, F.; Casuccio, A. Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation. Int. J. Environ. Res. Public Health 2018, 15, 770. [Google Scholar] [CrossRef] [Green Version]
  29. Baldovin, T.; Bertoncello, C.; Cocchio, S.; Fonzo, M.; Gazzani, D.; Buja, A.; Majori, S.; Baldo, V. Perception and knowledge of HPV-related and vaccine-related conditions among a large cohort of university students in Italy. Hum. Vaccin. Immunother. 2019, 15, 1641–1649. [Google Scholar] [CrossRef]
  30. Lai, D.; Bodson, J.; Davis, F.A.; Lee, D.; Tavake-Pasi, F.; Napia, E.; Villalta, J.; Mukundente, V.; Mooney, R.; Coulter, H.; et al. Diverse Families’ Experiences with HPV Vaccine Information Sources: A Community-Based Participatory Approach. J. Community Health 2017, 42, 400–412. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  31. Patel, P.R.; Berenson, A.B. The internet’s role in HPV vaccine education. Hum. Vaccin. Immunother. 2014, 10, 1166–1170. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Eysenbach, G.; Yihune, G.; Lampe, K.; Cross, P.; Brickley, D. MedCERTAIN: Quality management, certification and rating of health information on the Net. In Proceedings of the MIA Symposium, Los Angeles, CA, USA, 4–8 November 2000; pp. 230–234. [Google Scholar]
  33. HONcode. Available online: https://www.hon.ch/HONcode/ (accessed on 22 February 2022).
  34. Restivo, V.; Palmeri, S.; Bono, S.; Caracci, F.; Russo Fiorino, G.; Foresta, A.; Gaglio, V.; Graziano, G.; Marchese, V.; Maniglia, M.; et al. Knowledge and attitudes of parents after the implementation of mandatory vaccination in kindergartens of Palermo, Italy. Acta Biomed. 2020, 91, 41–47. [Google Scholar] [CrossRef]
  35. Grandahl, M.; Rosenblad, A.; Stenhammar, C.; Tydén, T.; Westerling, R.; Larsson, M.; Oscarsson, M.; Andrae, B.; Dalianis, T.; Nevéus, T. School-based intervention for the prevention of HPV among adolescents: A cluster randomised controlled study. BMJ Open 2016, 6, e009875. [Google Scholar] [CrossRef]
  36. Enerly, E.; Flingtorp, R.; Christiansen, I.K.; Campbell, S.; Hansen, M.; Myklebust, T.Å.; Weiderpass, E.; Nygård, M. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway. PLoS ONE 2019, 14, e0223612. [Google Scholar] [CrossRef]
  37. Unger, Z.; Maitra, A.; Kohn, J.; Devaskar, S.; Stern, L.; Patel, A. Knowledge of HPV and HPV Vaccine among Women Ages 19 to 26. Womens Health Issues 2015, 25, 458–462. [Google Scholar] [CrossRef]
  38. Benavidez, G.; Asare, M.; Lanning, B.; Ylitalo, K.; Fakhoury, C.; Thompson, N.; Boozer, K.; Mamudu, H.M. Young adults’ human papillomavirus-related knowledge: Source of medical information matters. Public Health 2020, 182, 125–130. [Google Scholar] [CrossRef]
  39. Restivo, V.; Cernigliaro, A.; Palmeri, S.; Sinatra, I.; Costantino, C.; Casuccio, A. The Socio-Economic Health Deprivation Index and its association with mortality and attitudes towards influenza vaccination among the elderly in Palermo, Sicily. J. Prev. Med. Hyg. 2019, 59, E26–E30. [Google Scholar] [CrossRef]
  40. Albright, A.E.; Allen, R.S. HPV Misconceptions Among College Students: The Role of Health Literacy. J. Community Health 2018, 43, 1192–1200. [Google Scholar] [CrossRef]
  41. Trezona, A.; Rowlands, G.; Nutbeam, D. Progress in Implementing National Policies and Strategies for Health Literacy-What Have We Learned so Far? Int. J. Environ. Res. Public Health 2018, 15, 1554. [Google Scholar] [CrossRef] [Green Version]
Table 1. Socio-demographic and behavioral characteristic of enrolled students and differences between fully or not vaccinated for HPV.
Table 1. Socio-demographic and behavioral characteristic of enrolled students and differences between fully or not vaccinated for HPV.
Total RespondentsVaccinated n (%)Unvaccinated n (%)p-Value
3073925 (30.1%)2148 (69.9%)
Age13–14 years old199 (6.5%)97 (10.5%)102 (4.8%)<0.001
15–16 years old419 (13.6%)185 (20.0%)234 (10.9%)
17–18 years old368 (11.9%)70 (7.6%)298 (13.9%)
19–20 years old500 (16.3%)204 (22.1%)296 (13.8%)
21–23 years old801 (26.1%)265 (28.7%)536 (24.9%)
24–26 years old539 (17.5%)801 (8.6%)459 (21.4%)
>26 years old247 (8.0%)24 (2.6%)223 (10.4%)
SexMale888 (28.9%)108 (11.7%) <0.001
780 (36.3%)
Female2185 (71.1%)817 (88.3%)1368 (63.7%)
Attended school/educationMedicine faculty453 (14.7%)570 (61.6%)1511 (70.3%)<0.001
Other faculties1628 (53%)
Lyceum876 (28.5%)355 (38.4%)637 (29.7%)
Technical institutes116 (3.8%)
FatherPrimary school diploma763 (25.50%)226 (24.9%)537 (25.8%)0.623
High school diploma1321 (44.2%)395 (43.6%)926 (44.5%)
Graduation903 (30.2%)285 (31.5%)618 (29.7%)
Worker3043 (99%)920 (99.5%)2123 (98.8%)0.107
Health worker273 (8.9%)84 (9.2%)189 (8.8%)0.768
MotherPrimary school diploma687 (23%)180 (19.8%)507 (24.3%)0.026
High school diploma1396 (46.6%)437 (48.1%)959 (46.0%)
Graduation910 (30.4%)291 (32.1%)619 (29.7%)
Worker2631 (85.6%)822 (88.9%)1809 (84.2%)0.001
Health worker264 (8.8%)74 (8.2%)190 (9.1%)0.414
Economic statusGood1472 (47.9%)495 (53.5%)977 (45.4%)<0.001
Acceptable1363 (44.4%)374 (40.4%)989 (46.0%)
Low238 (7.7%)56 (6.1%)182 (8.5%)
Smoking 676 (22%)177 (19.1%)499 (23.2%)0.012
AlcoholNever541 (17.6%)191 (20.7%)350 (16.3%)<0.001
occasionally2196 (71.5%)655 (70.8%)1541 (71.7%)
2 or 3 times in a week312 (10.8%)68 (7.4%)244 (11.4%)
every day24 (0.8%)11 (1.2%)13 (0.6%)
Sexual orientationHeterosexual2081 (91.1%)836 (90.4%)1965 (91.5%)0.028
Homosexual87 (2.8%)20 (2.2%)67 (3.1%)
Bisexual142 (4.6%)57 (6.2%)85 (3.9%)
Relationship statusSingle1357 (44.2%)415 (44.9%)942 (43.9%)0.872
Exclusive relationship1491 (48.5%)439 (47.5%)1052 (49%)
Nonexclusive relationship157 (5.1%)50 (5.4%)107 (5%)
First sexual intercourse12–14 years old203 (6.6%)62 (6.7%)141 (6.6%)<0.001
15–18 years old1321 (43%)373 (40.6%)945(44.9%)
<18 years old619 (20.1%)157 (16.9%)462 (21.5%)
Condom1735 (56.5%)487 (52.7%)124 (58.1%)<0.001
Contraceptive method usedOral contraceptive276 (9%)104 (11.2%)172 (8.0%)0.004
Nothing696 (22.6%)211 (22.8%)485 (22.6%)0.888
Table 2. HPV infection and HPV vaccine knowledge, and differences between fully or not vaccinated for HPV.
Table 2. HPV infection and HPV vaccine knowledge, and differences between fully or not vaccinated for HPV.
Total RespondentsVaccinated n (%)Unvaccinated n (%)p-Value
3073925 (30.1%)2148 (69.9%)
Have you been informed about sexually transmitted infections?Yes2699 (87.8%)820 (88.6%)1879 (87.5%)0.362
Papilloma virus568 (18.5%)160 (17.3%)409 (19.1%)0.254
What is the most common sexually transmitted disease?HIV1074 (34.9%)337 (36.4%)737 (34.3%)0.258
Genital herpes867 (28.2%)276 (29.8%)591 (27.5%)0.189
Do you think that HPV infection is sexually transmitted?Yes2821 (91.8%)834 (90.2%)1987 (92.5%)0.03
Do you think that the cervical cancer is due to HPV?Yes2008 (65.3%)646 (69.8%)1362 (63.4%)0.001
Do you think that the penile cancer is due to HPV?Yes559 (18.2%)176 (19.0%)383 (17.8%)0.43
Do you think that the prostate cancer is due to HPV?Yes609 (19.8%)208 (22.5%)401 (18.7%)0.015
Do you think that the Herpes infection is due to HPV?Yes282 (7.1%)68 (7.4%)214 (9.9%)0.021
Do you think HPV can cause infertility?Yes282 (9.2%)77 (8.32%)142 (6.6%)0.09
Are there therapies for HPV infection?Yes2460 (80.1%)745 (80.5%)1715 (79.8%)0.657
Have you ever heard about HPV vaccine?Yes2672 (87%)882 (95.4%)1790 (83.3%)<0.001
Parents532 (17.3%)257(27.8%)275 (12.8%)<0.001
School646 (21%)155 (16.7%)491 (22.9%)<0.001
Internet374 (12.2%)62 (6.7%)312 (14.5%)<0.001
What was your main source of information about the HPV vaccine?Information material given by public vaccination services134 (4.4%)58 (6.3%)76 (3.5%)0.001
Media259 (8.4%)41 (4.4%)218 (10.2%)<0.001
General pratictioner or pediatrician515 (16.8%)241 (26.1%)274 (12.8%)<0.001
Friends116 (3.8%)7 (0.8%)109 (5.1%)<0.001
Table 3. HBM and HL scores, and differences between fully or not vaccinated for HPV.
Table 3. HBM and HL scores, and differences between fully or not vaccinated for HPV.
Total RespondentsVaccinated n (%)Unvaccinated n (%)p-Value
3073925 (30.1%)2148 (69.9%)
HBM (Total score = 15)High HBM (≥12)1098 (35.7%)525 (56.8%)573 (26.7%)<0.001
Low HBM (<12)1975 (64.3%)400 (43.2%)1575 (73.3%)
Never971 (31.6%)247(26.7%)724 (33.7%)0.005
Rarely1339 (43.6%)436 (47.1%)903 (42.0%)
SILS testSometimes569 (18.5%)183 (19.8%)386 (17.9%)
Often158 (5.1%)48 (5.2%)110 (5.1%)
Always36 (1.2%)11 (1.2%)25 (1.2%)
Low level (0–20)596 (19.4%)163 (17.6%)433(20.2%)0.096
METER testMarginal level (21–34)876 (28.5%)285 (30.8%)591(27.5%)
Adequate level (35–40)1601 (52.1%)477 (51.6%)1124 (52.3%)
Table 4. Univariate and multivariate analysis of factors associated with HPV vaccination acceptance.
Table 4. Univariate and multivariate analysis of factors associated with HPV vaccination acceptance.
Crude
OR
p-ValueAdjusted ORp-Value
StudentsPalermo High SchoolRef
Palermo University0.67<0.0010.540.57
SexFemale vs. Male4.31<0.0014.43<0.001
Age13–14 years oldRef
15–16 years old0.830.2851.060.778
17–18 years old0.25<0.0010.19<0.001
19–20 years old0.720.0560.960.969
21–23 years old0.52<0.0010.70.747
24–26 years old0.18<0.0010.230.181
>26 years old0.11<0.0010.170.121
MotherWorker vs. nonworker1.490.0011.370.064
MotherEducational qualification1.320.0120.880.372
Graduation
Economic statusLowRef
Acceptable1.230.210.930.735
Good1.640.0021.080.708
SmokersYes vs. no0.780.0120.880.312
Sexual orientationHeterosexualRef
Homosexual0.70.171.160.646
Bisexual1.570.011.140.548
SILS testAlways1.290.4910.870.762
Often1.280.1910.760.252
Sometimes1.390.0051.030.807
Rarely1.42<0.0011.260.047
NeverRef
Meter testLow levelRef
Marginal level1.280.0340.890.422
Adequate level1.130.2620.870.323
High HBMTotal score ≥ 12 vs. <124.84<0.0014.23<0.001
Believing that HPV causes cervical cancer Yes vs. no1.340.0010.960.743
Believing that HPV causes Herpes infection Yes vs. no0.720.0220.670.044
Believing that HPV causes prostate cancerYes vs. no1.260.0150.90.489
Having heard about HPV vaccinationYes vs. no4.1<0.001
Information source about HPV vaccineParents (yes vs. no)2.62<0.0011.780.004
General pratictioner or paediatrician (yes vs. no)2.41<0.0011.880.001
Public vaccination services (yes vs. no)1.820.0011.970.001
Teachers/school (yes vs. no)0.68<0.0010.670.05
Internet (yes vs. no)0.42<0.0010.620.043
Media (yes vs. no)0.41<0.0010.620.067
Friends (yes vs. no)0.14<0.0010.280.007
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Fallucca, A.; Immordino, P.; Riggio, L.; Casuccio, A.; Vitale, F.; Restivo, V. Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines 2022, 10, 998. https://0-doi-org.brum.beds.ac.uk/10.3390/vaccines10070998

AMA Style

Fallucca A, Immordino P, Riggio L, Casuccio A, Vitale F, Restivo V. Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy. Vaccines. 2022; 10(7):998. https://0-doi-org.brum.beds.ac.uk/10.3390/vaccines10070998

Chicago/Turabian Style

Fallucca, Alessandra, Palmira Immordino, Luca Riggio, Alessandra Casuccio, Francesco Vitale, and Vincenzo Restivo. 2022. "Acceptability of HPV Vaccination in Young Students by Exploring Health Belief Model and Health Literacy" Vaccines 10, no. 7: 998. https://0-doi-org.brum.beds.ac.uk/10.3390/vaccines10070998

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop